PL3325080T3 - Sposoby lepszego dostarczania środków czynnych do guzów - Google Patents

Sposoby lepszego dostarczania środków czynnych do guzów

Info

Publication number
PL3325080T3
PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
Authority
PL
Poland
Prior art keywords
tumors
ways
active agents
better delivery
delivery
Prior art date
Application number
PL16831139T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics, Inc. filed Critical Sorrento Therapeutics, Inc.
Publication of PL3325080T3 publication Critical patent/PL3325080T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL16831139T 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów PL3325080T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors
EP16831139.7A EP3325080B1 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
PL3325080T3 true PL3325080T3 (pl) 2022-01-24

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831139T PL3325080T3 (pl) 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów

Country Status (15)

Country Link
US (3) US10806913B2 (pl)
EP (2) EP3925599A1 (pl)
JP (1) JP7082041B2 (pl)
KR (1) KR20180035209A (pl)
CN (2) CN118902979A (pl)
AU (3) AU2016297823B2 (pl)
BR (1) BR112018001292A2 (pl)
CA (1) CA2991455C (pl)
DK (1) DK3325080T3 (pl)
ES (1) ES2891523T3 (pl)
HU (1) HUE056410T2 (pl)
MX (2) MX2018000166A (pl)
PL (1) PL3325080T3 (pl)
RU (1) RU2719943C2 (pl)
WO (1) WO2017019526A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置
DK3325080T3 (da) * 2015-07-24 2021-10-04 Sorrento Therapeutics Inc Fremgangsmåder til bedre indgivelse af aktive midler til tumorer
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
ES3036948T3 (en) 2017-05-17 2025-09-25 Massachusetts Inst Technology Tissue anchoring articles
EP3652133A4 (en) 2017-07-10 2021-04-21 Basf Se MIXTURES WITH A UREA INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCIC ACID (DMPSA) OR 3,4-DIMETHYLPYRAZOLYL GLYCOLATE (DMPG)
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
EP3801464A4 (en) * 2018-05-31 2022-03-16 Sorrento Therapeutics, Inc. ANTI-LYMPHICAL SYSTEM-DIRECTED DRUG RELEASE METHODS
CN112752590A (zh) 2018-09-24 2021-05-04 欧莱雅 包含用于皮肤原位反应的微针的装置
CN112752591A (zh) * 2018-09-24 2021-05-04 欧莱雅 包含用于皮肤着色的微针的装置
IL293479A (en) 2019-12-05 2022-08-01 Sorrento Therapeutics Inc Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device
WO2022159736A1 (en) 2021-01-22 2022-07-28 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CN117916264A (zh) 2021-06-09 2024-04-19 索伦托药业有限公司 通过经由淋巴微针递送装置施用抗pd-1或抗pd-l1治疗剂来治疗癌症的方法
KR20240056524A (ko) 2021-08-18 2024-04-30 소렌토 쎄라퓨틱스, 인코포레이티드 림프계를 표적화하는 치료학적 제제
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
ATE253910T1 (de) * 2000-06-01 2003-11-15 Watson Pharmaceuticals Inc Transdermale verabreichung von lasofoxifen
ES2393282T3 (es) * 2001-09-12 2012-12-20 Becton, Dickinson And Company Dispositivo de pluma basado en microaguja para la administración de fármacos
AU2004264839B2 (en) 2003-06-13 2009-06-04 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
BRPI0414014A (pt) 2003-08-26 2006-10-24 Becton Dickinson Co métodos para distribuição intradérmica de agentes terapêuticos
AU2005284908B2 (en) * 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
WO2006138719A2 (en) * 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
PT2563450T (pt) 2010-04-28 2017-08-28 Kimberly Clark Co Dispositivo para entrega de medicação para a artrite reumatóide
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
WO2012046149A1 (en) 2010-04-28 2012-04-12 Kimberly-Clark Worldwide, Inc. Method for increasing permeability of an epithelial barrier
US9522262B2 (en) 2010-04-28 2016-12-20 Kimberly-Clark Worldwide, Inc. Medical devices for delivery of siRNA
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
RU2656156C2 (ru) 2011-10-17 2018-05-31 Массачусетс Инститьют Оф Текнолоджи Внутриклеточная доставка
CN104039382B (zh) * 2011-10-27 2018-01-12 金伯利-克拉克环球有限公司 高粘度生物活性剂的经皮递送
KR101575039B1 (ko) * 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
WO2014041531A1 (en) * 2012-09-13 2014-03-20 Amir Avraham Delivery devices and methods for skin augmentation
RU2657749C2 (ru) 2012-09-21 2018-06-15 Интенсити Терапьютикс, Инк Способы лечения рака
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
KR102370538B1 (ko) 2013-02-28 2022-03-07 소렌토 쎄라퓨틱스, 인코포레이티드 경피 약물 전달 장치
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
JP2016517762A (ja) 2013-05-23 2016-06-20 キンバリー クラーク ワールドワイド インコーポレイテッド 開放チャネル断面形状が改善されたマイクロニードル
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
DK3325080T3 (da) * 2015-07-24 2021-10-04 Sorrento Therapeutics Inc Fremgangsmåder til bedre indgivelse af aktive midler til tumorer
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置

Also Published As

Publication number Publication date
KR20180035209A (ko) 2018-04-05
US20180193624A1 (en) 2018-07-12
EP3325080A4 (en) 2019-04-17
AU2021200146B2 (en) 2022-08-25
DK3325080T3 (da) 2021-10-04
CN118902979A (zh) 2024-11-08
AU2016297823A1 (en) 2018-02-15
WO2017019526A2 (en) 2017-02-02
AU2022275397A1 (en) 2023-01-05
RU2018104102A3 (pl) 2019-11-06
EP3925599A1 (en) 2021-12-22
CA2991455C (en) 2023-10-10
EP3325080A2 (en) 2018-05-30
JP7082041B2 (ja) 2022-06-07
EP3325080B1 (en) 2021-09-01
MX2018000166A (es) 2018-03-26
AU2021200146A1 (en) 2021-03-18
RU2719943C2 (ru) 2020-04-23
US10806913B2 (en) 2020-10-20
JP2018521755A (ja) 2018-08-09
BR112018001292A2 (pt) 2018-09-11
CA2991455A1 (en) 2017-02-02
US20240238570A1 (en) 2024-07-18
HUE056410T2 (hu) 2022-02-28
US20210052871A1 (en) 2021-02-25
CN107921248A (zh) 2018-04-17
MX2022014277A (es) 2022-12-07
RU2018104102A (ru) 2019-08-27
ES2891523T3 (es) 2022-01-28
AU2016297823B2 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
PL3325080T3 (pl) Sposoby lepszego dostarczania środków czynnych do guzów
IL264901B (en) Administration of kynurenine depleting enzymes for tumor therapy
SI3350157T1 (sl) Sestave za doziranje terapevtskih sredstev v celice
PL3377516T3 (pl) Kompozycja do leczenia nowotworu
HUE047477T2 (hu) Palbociclib szilárd dózisformái
ZA201506916B (en) Microstructure array for delivery of active agents
PL3283527T3 (pl) Leczenie skojarzone nowotworów
HRP20181679T1 (hr) Amidni spojevi za liječenje hiv
PL3297605T3 (pl) Kompozycje farmaceutyczne do stosowania miejscowego
DK3107563T3 (da) Glycomålrettede terapeutiske midler
KR102494289B9 (ko) 활성 혼합물
PL3310904T3 (pl) Komórkowy układ ukierunkowanego dostarczania substancji czynnej
ME03465B (me) Farmaceutska kompozicija s-ketamin hidrohlorida
LT2981255T (lt) Empagliflozino terapiniai panaudojimo būdai
LT3116491T (lt) Terapiškai aktyvių junginių farmacinės kompozicijos
DK3234107T3 (da) B-celler til in vivo-levering af terapeutiske midler
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
PL3186244T3 (pl) Analogi dioksolanowe urydyny w leczeniu raka
MA39483A (fr) Agents thérapeutiques cibles
SI4119569T1 (sl) Konjugirane protismiselne spojine za uporabo v terapiji
HUE056424T2 (hu) Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására
IL256206A (en) Mct4 inhibitors for treating disease
DK3363428T3 (da) Perfusionsdoseringsform
HRP20181572T1 (hr) Režim doziranja spoja fgf-18
IL259101A (en) Melflufen dosage regimens for cancer